Prostate: Acapodene for PIN
This firm is soliciting participants to a Phase II clinical trial with the hormonal agent toremifene for use in prostatic intraepithelial neoplasia which is thought to be a precursor condition to prostate cancer.

Queries for www.gtxinc.com

Query User
gtx entered by user 1418082
gtx entered by user ditto
sarcopenia androgen receptor entered by user 1561252